Get an email when this journal's indexing changes
Added to or removed from Scopus, Web of Science, ABDC, DOAJ, FT50, UT Dallas or ONOS. One confirmation click; unsubscribe anytime.
Journal of Neuromuscular Diseases is Scopus-indexed (Q2, CiteScore 5.5), WoS SCIE. Published by SAGE Publications Ltd.
Checked against the index lists dated .
ISSN 2214-3599Verify ISSN ↗2214-3602Verify ISSN ↗
Publisher: SAGE Publications Ltd
Cost to publish: No APC data — check the publisher
| Subject area | Rank | Pctile | Q |
|---|---|---|---|
| Neurology (clinical) | 112 / 403 | 72nd | Q2 |
| Neurology | 60 / 201 | 70th | Q2 |
Not listed in: DOAJ, ABDC, ABS / AJG, FT50, UT Dallas, ONOS (subscription), ONOS (APC covered)
Yes — actively indexed in Scopus, coverage 2014–present, best quartile Q2, CiteScore 5.5.
Journal of Neuromuscular Diseases is Q2 in Neurology (clinical) (rank 112 of 403) and Q2 in Neurology (rank 60 of 201), by CiteScore 2025.
Journal of Neuromuscular Diseases is indexed in the Science Citation Index Expanded, so it may have a Journal Impact Factor in Clarivate's Journal Citation Reports. JCR is paid, so check it for the current value. The closest free measure is its Scopus CiteScore 5.5, which places it in quartile Q2 at the 72nd percentile of its subject. Its SCImago Journal Rank (SJR, a free Scopus-based metric) is 1.066, quartile Q1, with an H-index of 49.
Journal of Neuromuscular Diseases is published by SAGE Publications Ltd. Its print ISSN is 2214-3599 and its online ISSN is 2214-3602.
Yes — indexed in the Science Citation Index Expanded.
No — it is not registered as an open-access journal in DOAJ or Scopus.
Journal of Neuromuscular Diseases has an h-index of 57 and a 2-year mean of 3.04 citations per paper (OpenAlex). Its Scopus CiteScore is 5.5, quartile Q2. On 2-year citations it ranks #80 of 403 Scopus journals in Neurology (clinical).
Journal of Neuromuscular Diseases published 138 papers in 2025. 2026* is the year so far.
h-index, i10-index and 2-year mean citedness are open, licence-clear metrics from OpenAlex — not a proprietary impact factor. The subject rank counts only journals that OpenAlex has a figure for; it is not a Scopus or Clarivate ranking. Updated 2026-10-14.
In its latest 100 research articles (2025–2026), authors are most often from United States (18.6%), France (10.3%) and United Kingdom (10%).
Countries are counted fractionally, so a paper by authors from two countries counts half to each.
Scopus status: Active. No retracted papers are recorded. The Problematic Paper Screener flags none of its papers. These are indicators to check, not findings against the journal.
Retractions from OpenAlex; flags from the Problematic Paper Screener (Cabanac, Labbé & Magazinov, CC BY), 2026-09-21 export. A flag marks a paper for a closer look; it is not a finding against the journal.
Index data is curated from public sources (Scopus, Web of Science, ABDC, FT50, UT Dallas, DOAJ). CiteScore and quartiles reflect the latest available Scopus release. Always verify a journal's current status on its official source before submitting.
Comments load as you scroll here.